发明名称 |
QUINONE DERIVATIVE 2,3-DIMETHOXY-5-METHYL-6-(10-HYDROXYDECYL)-1,4-BENZOQUINONE FOR THE TREATMENT OF PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS |
摘要 |
The present invention relates to pharmaceuticals and uses thereof directed to the curative treating or preventing of Primary Progressive Multiple Sclerosis (PP-MS), by using 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone (Idebenone) as the active agent. |
申请公布号 |
HUE027428(T2) |
申请公布日期 |
2016.10.28 |
申请号 |
HUE09795720 |
申请日期 |
2009.12.18 |
申请人 |
Santhera Pharmaceuticals (Schweiz) AG;The United States of America as represented by the Department of Health and Human Services |
发明人 |
MEIER, Thomas;BIELEKOVA, Bibiana;MCFARLAND, Henry, F. |
分类号 |
A61P25/00 |
主分类号 |
A61P25/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|